|
|
|
|
|
|
|
|
|
Webinar: Driving Measurable Productivity Gains in CHO Cell Culture
|
Developers are under increasing pressure to improve productivity and accelerate process development — all while building on established media platforms and workflows. Join Thermo Fisher Scientific experts and they explore how targeted media supplementation can enhance CHO cell culture performance, accelerate upstream process development, and drive measurable productivity gains without disrupting established workflows. Click here to learn more.
|
|
|
|
|
|
Webinar | Cytiva
|
Discover how connected laboratory data and predictive modeling can strengthen process control, improve yield, and more.
|
|
|
|
|
|
Webinar | ATUM
|
In this presentation, experts provide insight into transposase-mediated genome engineering, genetic quality control, and the maintenance of genetic stability in cell line generation.
|
|
|
|
|
|
Video | Thermo Fisher Scientific Bioproduction
|
Witness a seamless cell therapy bioprocessing workflow that reduces manufacturing time and preserves the crucial cell phenotype.
|
|
|
|
|
|
Video | Bioprocess Online
|
In this closing segment from the Bioprocess Online Live event, panelists Sourav Kundu, Ph.D., and Will Olughu, Ph.D., discuss the transfer of analytical methods and importance of functionality assays in ADC development, as well as the traits of good CDMO partners.
|
|
|
|
|
|
Webinar | Repligen
|
Improve UF/DF repeatability by defining clear concentration and diafiltration endpoints, matching them with appropriate measurements, and applying real-time in-line analytics to reduce variability.
|
|
|
|
|
|
Webinar | Primrose Bio
|
Pseudomonas fluorescens offers a purpose-built alternative to conventional expression systems. Strain engineering platforms built around this organism can improve yields and simplify development.
|
|
|
|
|
|
|
|
|
|
Webinar: IND in as Little as 6 Months: Now Beyond mAbs
|
Accelerating biologics development doesn’t have to mean compromising quality or scalability. Join Lonza to explore expanded DNA-to-IND pathways for mAbs, bispecifics, Fc-fusions and high-concentration biologics. Through data, case studies and practical insights, discover how expression technologies, integrated CMC strategies and streamlined execution can reduce timelines, support IND readiness and enable efficient development from early stages through future milestones. Click here to learn more.
|
|
|
| Connect With Bioprocess Online: |
|
|
|
|
